Planta Med 2012; 78(7): 651-657
DOI: 10.1055/s-0031-1298379
Biological and Pharmacological Activity
Original Papers
© Georg Thieme Verlag KG Stuttgart · New York

Preventive Effect of Embelin from Embelia ribes on Lipid Metabolism and Oxidative Stress in High-Fat Diet-Induced Obesity in Rats

Hemantkumar Somabhai Chaudhari1 , Uma Bhandari1 , Geetika Khanna2
  • 1Department of Pharmacology, Faculty of Pharmacy, Jamia Hamdard (Hamdard University), New Delhi, India
  • 2Department of Pathology, Vardhman Mahavir Medical College, Safdarjung Hospital, New Delhi, India
Weitere Informationen

Publikationsverlauf

received Nov. 16, 2011 revised February 14, 2012

accepted February 17, 2012

Publikationsdatum:
26. März 2012 (online)

Abstract

A high-fat diet (HFD) results in hyperlipidemia and an increase in oxidative stress. The purpose of this study was to investigate the preventive effect of embelin against hyperlipidemia and oxidative stress in HFD-induced obesity in rats. Male Wistar rats aged 12 weeks (150–200 g) were fed with an HFD for a period of 28 days to induce experimental obesity. HFD-induced obese rats were treated with embelin (50 mg/kg) or orlistat (10 mg/kg) for 21 days. A range of parameters were tested including body weight gain, body mass index (BMI), blood pressure, visceral fat pad weights, serum levels of glucose, insulin, leptin, apolipoprotein B (ApoB), total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), hepatic thiobarbituric acid-reactive substances (TBARS), superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH). Twenty-one days of embelin (50 mg/kg) treatment produced effects similar to orlistat in reducing body weight gain, blood pressure, visceral fat pad weight, serum lipid levels, as well as coronary artery risk and atherogenic indices of HFD-fed rats. Embelin treatment also lowered the serum levels of glucose by 24.77 %, insulin by 35.03 %, and leptin by 43.39 %. Furthermore, embelin treatment significantly (p < 0.01) decreased the hepatic TBARS levels, while increasing the SOD, CAT, and GSH levels in obese rats. The present study indicated the preventive effect of embelin in HFD-induced obesity and its related complications. Embelin could be valuable in the development of new drug therapies to prevent obesity, hyperlipidemia, and oxidative stress.

References

  • 1 World Health Organization .Obesity: preventing and managing the global epidemic. Report of a WHO consultation. Geneva: World Health Organization Headquarters; 1997
  • 2 Slim R M, Toborek M, Watkins B A, Boissonneault G A, Hennig B. Susceptibility to hepatic oxidative stress in rabbits fed different animal and plant fats.  J Am Coll Nutr. 1996;  15 289-294
  • 3 Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and impact on metabolic syndrome.  J Clin Invest. 2004;  114 1752-1761
  • 4 Hamilton M. Strategies for the management of patients with obesity.  Treat Endocrinol. 2002;  1 21-36
  • 5 Wu T, Gao X, Chen M, van Dam R M. Long-term effectiveness of diet-plus-exercise interventions vs. diet-only interventions for weight loss: a meta-analysis.  Obes Rev. 2009;  10 313-323
  • 6 Raskin I, Ribnicky D M, Komarnytsky S, Ilic N, Poulev A, Borisjuk N, Brinker A, Moreno D A, Ripoll C, Yakoby N, O'Neal J M, Cornwell T, Pastor I, Fridlender B. Plants and human health in the twenty-first century.  Trends Biotechnol. 2002;  20 522-531
  • 7 Gupta O P, Ali M M, Ray Ghatak B J, Atal C K. Some pharmacological investigations of embelin and its semisynthetic derivatives.  Indian J Physiol Pharmacol. 1977;  21 31-39
  • 8 Mahendran S, Maithili V, Badami S. Evaluation of antidiabetic effect of embelin from Embelia ribes in alloxan induced diabetes in rats.  Biomed Pharmacother. advance online publication 2010;  DOI: 10.1016/j.biopha.2010.08.003
  • 9 Bhandari U, Kanojia R, Pillai K K. Effect of ethanolic extract of Embelia ribes on dyslipidemia in diabetic rats.  Int J Exp Diab Res. 2002;  3 159-162
  • 10 Bhandari U, Jain N, Pillai K K. Further studies on antioxidant potential and protection of pancreatic beta-cells by Embelia ribes in experimental diabetes.  Exp Diabetes Res. 2007;  2007 1-6
  • 11 Bhandari U, Jain N, Ansari M N, Pillai K K. Beneficial effect of Embelia ribes ethanolic extract on blood pressure and glycosylated hemoglobin in streptozotocin-induced diabetes in rats.  Fitoterapia. 2008;  79 351-355
  • 12 Pawloski C M, Kanagy N L, Mortensen L H, Fink G D. Obese Zucker rats are normotensive on normal and increased sodium intake.  Hypertension. 1992;  19 190-195
  • 13 Pathan R A, Bhandari U. Preparation & characterization of embelin-phospholipid complex as effective drug delivery tool.  J Incl Phenom Macrocycl Chem. 2011;  69 139-147
  • 14 Thippeswamy B S, Nagakannan P, Shivasharan B D, Mahendran S, Veerapur V P, Badami S. Protective effect of embelin from Embelia ribes Burm. against transient global ischemia-induced brain damage in rats.  Neurotox Res. 2011;  20 379-386
  • 15 Thippeswamy B S, Mahendran S, Biradar M I, Raj P, Srivastava K, Badami S, Veerapur V P. Protective effect of embelin against acetic acid induced ulcerative colitis in rats.  Eur J Pharmacol. 2011;  654 100-105
  • 16 Novelli E L B, Diniz Y S, Galhardi C M, Ebaid G M X, Rodrigues H G, Mani F, Fernandes A A H, Cicogna A C, Novelli Filho J L V B. Anthropometrical parameters and markers of obesity in rats.  Lab Anim. 2007;  41 111-119
  • 17 Friedewald W T, Levy R I, Fredrickson D S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.  Clin Chem. 1972;  18 499-502
  • 18 Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FERHDL).  Clin Biochem. 2001;  34 583-588
  • 19 Alladi S, Shanmugasundaram K R. Induction of hypercholesterolaemia by supplementing soy protein with acetate generating amino-acids.  Nutr Rep Int. 1989;  40 893-899
  • 20 Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid.  Anal Biochem. 1979;  95 359-364
  • 21 Calberg I, Mannerviek B. Glutathione reductase levels in rat brain.  J Biol Chem. 1975;  250 5475-5480
  • 22 Marklund S, Marklund G. Involvement of the superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase.  Eur J Biochem. 1974;  47 469-474
  • 23 Caliborne A L. Assay of catalase. In: Greenwald R A, editor Handbook of methods of oxygen radical research. Baco Raton, London (UK): CRC Press; 1985: 283-285
  • 24 Rizvi F, Iftikhar M, George J P. Beneficial effects of fish liver preparations of sea bass (Lates calcarifer) versus gemfibrozil in high fat diet-induced lipid-intolerant rats.  J Med Food. 2003;  6 123-128
  • 25 Kennett G A, Clifton P G. New approaches to the pharmacological treatment of obesity: can they break through the efficacy barrier?.  Pharmacol Biochem Behav. 2010;  97 63-83
  • 26 Knight S F, Imig J D. Obesity, insulin resistance, and renal function.  Microcirculation. 2007;  14 349-362
  • 27 MacMahon S, Cutler J, Brittain E, Higgins M. Obesity and hypertension: epidemiological and clinical issues.  Eur Heart J. 1987;  8 57-70
  • 28 Brown J L, Spicer M T, Spicer L J. Effect of high-fat diet on body composition and hormone responses to glucose tolerance tests.  Endocrine. 2002;  19 327-332
  • 29 Mertens I L, Van Gaal L F. Overweight, obesity, and blood pressure: the effects of modest weight reduction.  Obes Res. 2000;  8 270-278
  • 30 Liu C H, Hung M T, Huang P C. Source of triacylglycerol accumulation in lives of rats fed a cholesterol-supplemented diet.  Lipids. 1995;  30 527-531
  • 31 Staiger H, Haring H U. Adipocytokines: fat-derived humoral mediators of metabolic homeostasis.  Exp Clin Endocrinol Diabetes. 2005;  113 67-79
  • 32 Matsubara M, Chiba H, Maruoka S, Katayose S. Elevated serum leptin concentrations in women with components of multiple risk factor clustering syndrome.  J Atheroscler Thromb. 2000;  7 231-237
  • 33 Hasty H A, Gruen M L, Terry E S, Surmi B K, Atkinson R D, Gao L, Morrow J D. Effects of vitamin E on oxidative stress and atherosclerosis in an obese hyperlipidemic mouse model.  J Nutr Biochem. 2007;  18 127-133
  • 34 Vincent H K, Innes K E, Vincent K R. Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity.  Diabetes Obes Metab. 2007;  9 813-839
  • 35 Ansari J A, Bhandari U, Haque S E, Pillai K K. Enhancement of antioxidant defense mechanism by pitavastatin and rosuvastatin on obesity-induced oxidative stress in Wistar rats.  Toxicol Mech Methods. advance online publication 2011;  DOI: 10.3109/15376516.2011.603391

Dr. Uma Bhandari, Associate Professor

Department of Pharmacology, Faculty of Pharmacy
Jamia Hamdard (Hamdard University)

Hamdard Nagar

New Delhi 110062

India

Telefon: +91 11 26 05 96 88

Fax: +91 11 26 05 96 63

eMail: uma_bora@hotmail.com